Innovation

Blog Post

Year of Independence

By Maggie Callahan | June 30, 2022
Blog Post

Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS

By Sujatha Gurunathan | June 1, 2022
FRDA
Blog Post

Simply Stated: What is Friedreich’s Ataxia (FRDA)?

By Sujatha Gurunathan | May 31, 2022
Featured Article

The Smart Home’s New Story

By MDA Staff | May 13, 2022
Blog Post

Brain-Computer Interface Technology Could Improve Life for Millions

By Larry Luxner | May 9, 2022
muscular dystrophy survey
Blog Post

Research Study Alert: Study of Wearable Gait Sensor in People with or without Neuromuscular Disease

By Sujatha Gurunathan | May 2, 2022

FDA Approves Alexion’s Ultomiris for Treatment of gMG

By Sujatha Gurunathan | April 28, 2022
Blog Post

Simply Stated: Inclusion Body Myositis, Revisited

By Sujatha Gurunathan | April 27, 2022
Blog Post

Natural History Trial of BMD Now Enrolling

By Sujatha Gurunathan | April 15, 2022
Blog Post

Promoting Diversity in Rare Disease Research

By Larry Luxner | April 8, 2022